Regulated Information

Monthly information relative to the total number of voting rights and shares composing the share capital

PARIS, FRANCE, 12 March 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Michelle C. Werner as Executive Vice President (EVP), President of North America, effective 23 March 2026. Michelle will serve on the Executive Leadership Team…

PARIS, FRANCE, 09 March 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s decision to withdraw is based on emerging data from the ongoing Phase Ib/III…

Ipsen S.A. publishes its 2025 Consolidated Financial Statements

Monthly information relative to the total number of voting rights and shares composing the share capital